Prestige BioPharma Limited
Biopharmaceutical company developing antibody therapeutics and biosimilars.
950210 | KO
Overview
Corporate Details
- ISIN(s):
- KR8702070002
- LEI:
- Country:
- Singapore
- Address:
- 21 BIOPOLIS ROAD #04-24 NUCLEOS, SINGAPORE
- Website:
- https://prestigebiopharma.com/
- Sector:
- Manufacturing
Description
Prestige BioPharma Limited is a biopharmaceutical company specializing in the discovery, development, and commercialization of antibody-based therapeutics. The company's portfolio is centered on two primary areas: the development of high-quality biosimilars and the creation of innovative, first-in-class antibody drugs. Its operations encompass the full drug development lifecycle, including preclinical and clinical research, alongside Chemistry, Manufacturing, and Controls (CMC) activities. Prestige BioPharma maintains a diverse pipeline of drug candidates in various stages of development, focusing on advancing biopharmaceutical technologies to provide novel therapeutic solutions for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-02-13 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.8 KB | ||
| 2025-01-09 00:00 |
임원ㆍ주요주주특정증권등거래계획보고서
|
Korean | 37.9 KB | ||
| 2024-12-06 00:00 |
[기재정정]투자판단관련주요경영사항
|
Korean | 10.7 KB | ||
| 2024-11-29 00:00 |
분기보고서 (2024.09)
|
Korean | 1.3 MB | ||
| 2024-10-04 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.7 KB | ||
| 2024-09-30 00:00 |
유가증권시장상장외국법인외부감사인선임ㆍ해임ㆍ변경신고서
|
Korean | 5.2 KB | ||
| 2024-09-27 00:00 |
정기주주총회결과
|
Korean | 26.2 KB | ||
| 2024-09-23 00:00 |
투자판단관련주요경영사항 (투즈뉴 (Tuznue, HD201)에 대한 유럽연합진행위원회(EC) 최종판매허가 획득)
|
Korean | 9.2 KB | ||
| 2024-09-19 00:00 |
감사보고서제출
|
Korean | 21.8 KB | ||
| 2024-09-19 00:00 |
사업보고서 (2024.06)
|
Korean | 1.7 MB | ||
| 2024-09-12 00:00 |
유상증자결정(종속회사의주요경영사항)
|
Korean | 24.4 KB | ||
| 2024-09-12 00:00 |
타법인주식및출자증권취득결정
|
Korean | 17.1 KB | ||
| 2024-09-12 00:00 |
주주총회소집결의
|
Korean | 14.2 KB | ||
| 2024-09-12 00:00 |
주주총회소집공고
|
Korean | 142.8 KB | ||
| 2024-08-14 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변경
|
Korean | 19.4 KB |
Automate Your Workflow. Get a real-time feed of all Prestige BioPharma Limited filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Prestige BioPharma Limited
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Prestige BioPharma Limited via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
